Ishida R, Takahashi T
Laboratory of Biochemistry, Aichi Cancer Center Research Institute, Nagoya, Japan.
Carcinogenesis. 1988 Jun;9(6):1079-83. doi: 10.1093/carcin/9.6.1079.
To clarify the involvement of O6-methylguanine (O6-MeG) in mutagenesis, we have been trying to isolate Mer+ cells from a HeLa S3 Mer- cell line, and to compare the mutation frequencies between the cell lines. We previously isolated the N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-resistant cells, MR10-1, from HeLa S3 Mer- cells. However, the MR10-1 cells still had only a little O6-MeG-DNA methyltransferase (MT) activity. In the present study, we have isolated two 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU)-resistant cells, ACr41 and ACr42, from the MR10-1 cells. The two ACr cells had increased MT activities. The ACr cells were also significantly more resistant to 1-(2-chloroethyl)-1-nitrosourea and slightly more resistant to MNNG than the MR10-1 cells. When the mutation frequencies were tested at the hypoxanthine-guanine phosphoribosyl transferase and ouabain loci in these cell lines, the two ACr cells were more resistant to the mutagenic effect of MNNG than the MR10-1 cells. These results show the linkage between the resistance to the cytotoxic effect of nitrosourea compounds and MT activity, and strongly support the hypothesis that O6-MeG is the main pre-mutagenic lesion induced by MNNG.
为阐明O6-甲基鸟嘌呤(O6-MeG)在诱变中的作用,我们一直试图从HeLa S3 Mer-细胞系中分离出Mer+细胞,并比较这些细胞系之间的突变频率。我们之前从HeLa S3 Mer-细胞中分离出了对N-甲基-N'-硝基-N-亚硝基胍(MNNG)具有抗性的细胞MR10-1。然而,MR10-1细胞仍然只有少量的O6-MeG-DNA甲基转移酶(MT)活性。在本研究中,我们从MR10-1细胞中分离出了两个对1-(4-氨基-2-甲基-5-嘧啶基)甲基-3-(2-氯乙基)-3-亚硝基脲(ACNU)具有抗性的细胞ACr41和ACr42。这两个ACr细胞的MT活性有所增加。与MR10-1细胞相比,ACr细胞对1-(2-氯乙基)-1-亚硝基脲的抗性也显著增强,对MNNG的抗性略有增强。当在这些细胞系的次黄嘌呤-鸟嘌呤磷酸核糖基转移酶和哇巴因位点测试突变频率时,这两个ACr细胞对MNNG的诱变作用比MR10-1细胞更具抗性。这些结果表明了对亚硝基脲化合物细胞毒性作用的抗性与MT活性之间的联系,并有力地支持了O6-MeG是由MNNG诱导的主要诱变前损伤的假说。